Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Zhejiang Hisun Biomaterials Co's Days Inventory for the quarter that ended in Jun. 2026 was 66.75.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Hisun Biomaterials Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.37.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Hisun Biomaterials Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.63.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Hisun Biomaterials Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Biomaterials Co Change In Inventory Related Terms
Zhejiang Hisun Biomaterials Co Change In Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Biomaterials Co Change In Inventory Chart
Zhejiang Hisun Biomaterials Co Change In Inventory Calculation
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥ Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Biomaterials Co (SHSE:688203) has a Change In Inventory of ¥ Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Zhejiang Hisun Biomaterials Co and its competitors.
Is Zhejiang Hisun Biomaterials Co's Change In Inventory too high?
Zhejiang Hisun Biomaterials Co's current Change In Inventory is ¥ Mil. Overall, Zhejiang Hisun Biomaterials Co has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Biomaterials Co's Change In Inventory compare to DOW?
Zhejiang Hisun Biomaterials Co's Change In Inventory of ¥ Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Chemicals company?
A good Change In Inventory depends on the Chemicals industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Zhejiang Hisun Biomaterials Co and its competitors. Zhejiang Hisun Biomaterials Co's current Change In Inventory is ¥ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Biomaterials Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Biomaterials Co (SHSE:688203) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥14.13, compared to a current price of ¥20.88 — trading 47.8% above its estimated fair value. The current Change In Inventory is ¥ Mil. Zhejiang Hisun Biomaterials Co's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Zhejiang Hisun Biomaterials Co (SHSE:688203), the current Change In Inventory is ¥ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Hisun Biomaterials Co (SHSE:688203) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Hisun Biomaterials Co stock appears to be overvalued.
The current stock price of ¥20.88 is trading 47.8% above its estimated GF Value™ of ¥14.13.
GuruFocus considers Zhejiang Hisun Biomaterials Co to be Significantly Overvalued.
Key valuation signals for SHSE:688203:
Change In Inventory: ¥ Mil
GF Value™: ¥14.13 vs. price of ¥20.88 (47.8% above fair value)
No single metric tells the full story. See the SHSE:688203 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Hisun Biomaterials Co Ltd is a Chinese manufacturer of biodegradable plastics, primarily polylactic acid (PLA), based in Zhejiang province. The company develops, produces, and sells polylactic acid resins and related products derived from renewable plant-based feedstocks such as corn starch. Its materials are used in applications including packaging, disposable tableware, fibers, textiles, and agricultural films, serving customers that seek compostable or biodegradable alternatives to conventional petroleum-based plastics. The company operates within the broader Hisun group and sells primarily in the Chinese market while also exporting to international customers. Revenue is generated through the sale of PLA resins and compounded or modified biodegradable materials, with pricing influenced by feedstock costs and global bioplastics demand. As a listed company on China's STAR Market, it is part of the country's emerging bio-based materials sector.
76GF Score
Get the complete analysis for SHSE:688203
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688203 has been successfully added to your 
